Psychopharmacology in supportive care of cancer: A review for the clinician. II. Neuroleptics

Supportive Care in Cancer

Volumn 8, Issue 2, 2000, Pages 89-97

  Mazzocato, C ^a   Stiefel, F ^a   Buclin, T ^a   Berney, A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cancer; Delirium; Neuroleptics; Palliative care; Psychotropics

Indexed keywords

ENZYME INHIBITOR; NEUROLEPTIC AGENT;

ADVANCED CANCER; ANXIETY; CANCER PAIN; CANCER PALLIATIVE THERAPY; DELIRIUM; DYSTONIA; HUMAN; NAUSEA; PRIORITY JOURNAL; REVIEW; VOMITING;

EID: 0034009424     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050021     Document Type: Review

References (93)

1. Adams F (1984) Neuropsychiatric evaluation and treatment of delirium in the critically ill cancer patient. Cancer Bull 36:156-160
2. Adams F, Fernandez F, Andersson BS (1986) Emergency pharmacotherapy of delirium in the critically ill cancer patient. Psychosomatics 27 [1 Suppl]:33-38
3. Adler LA, Angrist B, Reiter S, Rotrosen J (1989) Neuroleptic-induced akathisia: a review. Psychopharmacology 97:1-11
4. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. APA, Washington, DC
5. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. APA, Washington, DC, pp 81-85
6. Baines MJ (1994) Intestinal obstruction. Cancer Surv 21:147-156
7. Balant-Gorgia AE, Balant LP, Andreoli A (1993) Pharmacokinetic optimisation of the treatment of psychosis. Clin Pharmacokinet 25:217-236
8. Beaver WT, Wallenstein SL, Houde RW, Rogers A (1966) A comparison of the analgesic effects of methotrimeprazine and morphine in patients with cancer. Clin Pharmacol Ther 7:436-446
9. Berney A, Stiefel F, Mazzocato C, Buclin T (1999) Psychopharmacology in supportive care of cancer: review for the clinician. III. Antidepressants. Support Care Cancer (submitted for publication)
10. Bloomfield S, Simard-Savoie S, Bernier J, Tetreault L (1964) Comparative analgesic activity of levopromazine and morphine in patients with chronic pain. Can Med Assoc J 90:1156-1159
11. Bottomley DM, Hanks GW (1990) Subcutaneous midazolam infusion in palliative care. J Pain Symptom Manage 5:259-261
12. Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobson P (1996) A double-blind trial of haloperidol, chlorpromazine and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153:231-237
13. Breitbart W, Chochinov HM, Passik S (1998) Psychiatric aspects of palliative care. In: Doyle D, Hanks GW, MacDonald N (eds) Oxford textbook of palliative medicine, 2nd edn. Oxford University Press, Oxford New York Tokyo, pp 933-954
14. Breivik H, Rennemo F (1982) Clinical evaluation of combined treatment with methadone and psychotropic drugs in cancer patients. Acta Anaesth Scand [Suppl] 74:135-140
15. Bruera E, Chadwick S, Weinlick A, MacDonald N (1987) Delirium and severe sedation in patient with terminal cancer. Cancer Treat Rep 71:787-788
16. Bruera E, Miller L, McCallion J, MacMillan K, Krefting L, Hanson J (1992) Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 7:192-195
17. Bruera E, Schoeller T, Montejo G (1992) Organic hallucinosis in patients receiving high doses of opiates for cancer pain. Pain 48:397-399
18. Bruera E, Franco JJ, Maltoni M, Watanabe S, Suarez-Almazor M (1995) Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydratation, and opioid rotation. J Pain Symptom Manage 10:287-291
19. Bruera E, Seifert L, Watanabe S, Babul N, Darke A, Harsanyi Z, Suarez-Almazor M (1996) Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manage 11:147-153
20. Burke AL, Diamond PL, Hulbert J, Yeatman J, Farr EA (1991) Terminal restlessness - its management and the role of midazolam. Med J Aust 155:485-487
21. Clouston PD, De Angelis LM, Posner JB (1992) The spectrum of neurological disease in patients with systemic cancer. Ann Neurol 31:268-273
22. Cole MG, Primeau FJ (1993) Prognosis of delirium in elderly hospital patients. Can Med Assoc 149:41-46
23. Cole RM, Robinson F, Harvey L, Trethowan K, Murdoch V (1994) Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer. J Pain Symptom Manage 9:48-50
24. Cowap J, Hardy J (1998) Thioridazine in the management of cancer-related sweating. J Pain Symptom Manage 15:266
25. Coyle N, Breitbart W, Weaver S, Portenoy R (1994) Delirium as a contributing factor of "crescendo" pain. J Pain Symptom Manage 9:44-47
26. Davidsen O, Lindeneg O, Walsh M (1979) Analgesic treatment with levomepromazine in acute myocardial infarction. A randomized clinical trial. Acta Med Scand 205:191-194
27. Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751-757
28. De Stoutz ND, Stiefel F (1997) Assessment and management of reversible delirium. In: Portenoy RK, Bruera E (eds) Topics in palliative care, vol 1. Oxford University Press, New York Oxford, pp 21-43
29. De Stoutz ND, Tapper M, Fainsinger RL (1995) Reversible delirium in terminally ill patients. J Pain Symptom Manage 10:249-253
30. Fainsiger R, Bruera E (1992) Treatment of delirium in a terminally ill patient. J Pain Symptom Manage 7:54-56
31. Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T (1991) Symptom control during the last week of life on a palliative care unit. J Palliat Care 7:5-11
32. Fainsiger RL, Tapper M, Bruera E (1993) A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliat Care 9:4-8
33. Fainsinger RL, Spachynski K, Hanson J, Bruera E (1994) Symptom control in terminally ill patients with malignant bowel obstruction (MBO). J Pain Symptom Manage 9:12-18
34. Fernandez F, Holmes VF, Adams F, Kavanaugh JJ (1988) Treatment of severe, refractory agitation with a haloperidol drip. J Clin Psychiatry 49:239-241
35. Fernandez F, Levy JK, Mansell PW (1989) Management of delirium in terminally ill AIDS patients. Int J Psychiatry Med 19:165-172
36. Fleishman SB, Lesko LM, Breitbart W (1993) Treatment of organic mental disorders in cancer patients. In: Breitbart W, Holland JC (eds) Psychiatric aspects of symptom management in cancer patients. American Psychiatric Press, Washington, pp 23-47
37. Francis J, Martin D, Kapoor WN (1990) A prospective study of delirium in hospitalized elderly. JAMA 263:1097-1101
38. Goff DC, Baldessarini RJ (1993) Drug interactions with antipsychotic agents. J Clin Psychopharmacol 13:57-67
39. Grond S, Zech D, Diefenbach C, Bischoff A (1994) Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 9:372-382
40. Hakkarainen H (1977) Fluphenazine for tension headache; double-blind study. Headache 17:216-218
41. Hansen TE, Casey DE, Hoffman WF (1997) Neuroleptic intolerance. Schizophr Bull 23:567-582
42. Hewitt DJ, Portenoy RK (1998) Adjuvant drugs for neuropathic cancer pain. In: Portenoy RK, Bruera E (eds) Topics in palliative care, vol 2. Oxford University Press, New York Oxford, pp 41-62
43. Holloman LC, Marder SR (1997) Management of acute extrapyramidal effects induced by antipsychotic drugs. Am J Health Syst Pharm 54:2461-2477
44. Ingham J, Breitbart W (1997) Epidemiology and clinical features of delirium. In: Portenoy RK, Bruera E (eds) Topics in palliative care, vol 1. Oxford University Press, New York Oxford, pp 7-19
45. Ison PJ, Peroutka SJ (1986) Neurotransmitter receptor binding studies predict antiemetic efficacy and side effects. Cancer Treat Rep 70:637-641
46. Lasagna L, DeKornfeld TJ (1961) Methotrimeprazine, a new phenothiazine derivative with analgesic properties. JAMA 178:887-890
47. Launois S, Bizec JL, Whitelaw WA, Cabane J, Derenne JP (1993) Hiccup in adults: an overview. Eur Respir J 6:563-575
48. Lechin F, van der Dijs B, Lechin ME, Amat J, Lechin AE, Cabrera A, Gomez F, et al (1989) Pimozine therapy for trigeminal neuralgia. Arch Neurol 46:960-963
49. Levine PM, Silberfarb PM, Lipowski ZJ (1978) Mental disorders in cancer patients: a study of 100 psychiatric referrals. Cancer 42:1385-1391
50. Levkoff SE, Liptzin B, Cleary P, Reilly CH, Evans D (1991) Review of research instruments and techniques used to detect delirium. Int Psychogeriatr 3:253-271
51. Leysen JE, Janssen PMF, Heylen L, Gommeren W, Van Gompel P, Lesage AS, et al (1998) Receptor interactions of new antipsychotics: relation to pharmacodynamic and clinical effects. Int J Psychiatry Clin Pract 2:513-517
52. Lichter I (1993) Results of antiemetic management in terminal illness. J Palliat Care 9:19-21
53. Lichter I (1993) Which antiemetic? J Palliat Care 9:42-50
54. Lipowski ZJ (1987) Delirium (acute confusional states). JAMA 258:1789-1792
55. Lipowski ZJ (1992) Update on delirium. Psychiatr Clin North Am 15:335-346
56. Massie MJ, Holland J, Glass E (1983) Delirium in terminally ill cancer patients. Am J Psychiatry 140:1048-1050
57. McIver B, Walsh D, Nelson K (1994) The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 9:341-345
58. McNamara P, Minton M, Twycross RG (1991) Use of midazolam in palliative care. Palliat Med 5:244-249
59. Mercadante S (1995) Bowel obstruction in home-care cancer patients: 4 years' experience. Support Care Cancer 3:190-193
60. Meyer MC, Baldessarini RJ, Goff DC, Centorrino F (1996) Clinically significant interactions of psychotropic agents with antipsychotic drugs. Drug Safety 15:333-346
61. Ng K, von Gunten CF (1998) Symptoms and attitudes of 100 consecutive patients admitted to an acute hospice/ palliative care unit. J Pain Symptom Manage 16:307-315
62. Oliver DJ (1985) The use of methotrimeprazine in terminal care. Br J Clin Pract 39:339-340
63. Olofsson SM, Weitzner MA, Valentine AD, Baile WF, Meyers CA (1996) A retrospective study of the psychiatric management and outcome of delirium in the cancer patient. Support Care Cancer 4:351-357
64. Owens DG (1996) Adverse effects of antipsychotic agents. Do newer agents offer advantages? Drugs 51:895-930
65. Passik SD, Cooper M (1999) Complicated delirium in a cancer patient successfully treated with olanzapine. J Pain Symptom Manage 17:219-223
66. Patt RB, Proper G, Reddy S (1994) The neuroleptics as adjuvant analgesics. J Pain Symptom Manage 9:446-453
67. Peroutka SJ, Snyder SH (1982) Antiemetics: neurotransmitter receptor binding predicts therapeutic action. Lancet I:658-659
68. Pittelkow MR, Loprinzi CL (1998) Pruritus and sweating. In: Doyle D, Hanks GW, MacDonald N (eds) Oxford textbook of palliative medicine, 2nd edn. Oxford University Press, Oxford New York Tokyo, pp 627-642
69. Potenza MN, McDougle CJ (1998) Potential of atypical antipsychotics in the treatment of nonpsychotic disorders. CNS Drugs 9:213-232
70. Rabins PV (1991) Psychosocial and management aspects of delirium. Int Psychogeriatr 3:319-324
71. Regnard C (1996) Use of low dose thioridazine to control sweating in advanced cancer. Palliat Med 10:78-79
72. Reuben DB, Mor V (1986) Nausea and vomiting in terminal cancer patients. Arch Intern Med 146:2021-2023
73. Rice KL, Kronenberg RS, Hedemark LL, Niewoehner DE (1987) Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction. Br J Dis Chest 81:287-292
74. Richelson E (1985) Pharmacology of neuroleptics in use in the United States. J Clin Psychiatry 46:8-14
75. Ross CA, Peyser CE, Shapiro I, Folstein MF (1991) Delirium: phenomenologic and etiologic subtypes. Int Psychogeriatr 3:135-147
76. Schor JD, Levkoff SE, Lipsitz LA, Reilly CH, Cleary PD, Rowe JW, Evans DA (1992) Risk factors for delirium in hospitalized elderly. JAMA 267:827-831
77. Stiefel F, Faisinger R, Bruera E (1992) Acute confusional states in patients with advanced cancer. J Pain Symptom Manage 7:94-98
78. Stiefel F, Berney A, Mazzocato C (1999) Psychopharmacology in supportive care of cancer: review for the clinician. I. Benzodiazepines. Support Care Cancer (7:379-385)
79. Stiefel F, Mazzocato C, Buclin T, Berney A (1999) Psychopharmacology in supportive care of cancer: review for the clinician. IV. Other psychotropics. Support Care Cancer (in preparation)
80. Stiefel FC, Kornblith AB, Holland JC (1990) Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period. Cancer 65:1048-1053
81. Tanaka K, Akechi T, Yamazaki M, Hayashi R, Nishiwaki Y, Uchitomi Y (1998) Neuroleptic malignant syndrome during haloperidol treatment in a cancer patient. A case report. Support Care Cancer 6:536-538
82. Taub A (1973) Relief of postherpetic neuralgia with psychotropic drugs. J Neurosurg 39:235-239
83. Trzepacz P (1994) The neuropathogenesis of delirium. A need to focus our research. Psychosomatics 35:374-391
84. Trzepacz P, Breitbart W, Franklin J, Levenson J, Martini DR (1999) Practice guideline for the treatment of patients with delirium. Am J Psychiatry 156 [Suppl]:1-20
85. Twycross R, Back I (1998) Nausées et vomissements dans le cancer avancé. Eur J Palliat Care 5:39-45
86. Twycross R, Barkby GD, Hollwood PM (1997) The use of low dose levomepromazine (methotrimeprazine) in the management of nausea and vomiting. Prog Palliat Care 5:49-53
87. Velamoor VR, Swamy GN, Parmar RS, Williamson P, Caroff SN (1995) Management of suspected neuroleptic malignant syndrome. Can J Psychiatry 40:545-550
88. Ventafridda V, Ripamonti C, De Conno F, Tamburini M, Cassileth BR (1990) Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 6:7-11
89. Walker P, Watanabe S, Bruera E (1998) Baclofen, a treatment for chronic hiccup. J Pain Symptom Manage 16:125-132
90. Weis O, Sriwatanakul K, Weintraub M (1982) Treatment of post-herpetic neuralgia and acute herpetic pain with amitriptyline and perphenazine. S Afr Med J 62:274-275
91. Woodcock AA, Gross ER, Geddes DM (1981) Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. BMJ [Res] 283:343-346
92. Zarate CA, Baldessarini RJ, Siegel AJ, Nakamura A, McDonald J, Muir-Hutchinson LA, Cherkerzian T, Tohen M (1997) Risperdone in the elderly: a pharmacoepidemiologic study. J Clin Psychol 58:311-317
93. Zimberg M, Berenson S (1990) Delirium in patients with cancer: nursing assessment and intervention. Oncol Nurs Forum 17:529-538